Perceptive Advisors as of June 30, 2019
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 103 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Solid Biosciences | 9.4 | $452M | 3.9M | 115.00 | |
| Neurocrine Biosciences (NBIX) | 7.1 | $340M | 4.0M | 84.43 | |
| Global Blood Therapeutics In | 6.3 | $304M | 5.8M | 52.60 | |
| Mirati Therapeutics | 6.2 | $299M | 2.9M | 103.00 | |
| Iovance Biotherapeutics (IOVA) | 6.1 | $292M | 12M | 24.52 | |
| Amicus Therapeutics (FOLD) | 5.6 | $268M | 22M | 12.48 | |
| Athenex | 3.9 | $188M | 9.8M | 19.10 | |
| Bridgebio Pharma (BBIO) | 3.8 | $181M | 6.7M | 26.97 | |
| Zogenix | 3.5 | $168M | 3.5M | 47.78 | |
| Meiragtx Holdings (MGTX) | 3.2 | $156M | 6.0M | 25.93 | |
| Amarin Corporation | 2.5 | $120M | 6.2M | 19.39 | |
| Blueprint Medicines (BPMC) | 2.4 | $114M | 1.2M | 94.33 | |
| Quotient | 2.1 | $101M | 11M | 9.35 | |
| Arena Pharmaceuticals | 1.7 | $81M | 1.4M | 58.63 | |
| Retrophin | 1.6 | $76M | 3.8M | 20.09 | |
| Nevro (NVRO) | 1.5 | $74M | 1.1M | 64.83 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.4 | $65M | 2.6M | 25.00 | |
| Myokardia | 1.1 | $55M | 1.1M | 50.14 | |
| Albireo Pharma | 1.1 | $55M | 1.7M | 32.24 | |
| Ascendis Pharma A S (ASND) | 1.1 | $55M | 474k | 115.15 | |
| Zymeworks | 1.1 | $52M | 2.4M | 22.00 | |
| Dova Pharmaceuticals | 1.1 | $50M | 3.6M | 14.10 | |
| Regenxbio Inc equity us cm (RGNX) | 1.0 | $50M | 971k | 51.37 | |
| Merit Medical Systems (MMSI) | 1.0 | $49M | 817k | 59.56 | |
| Array BioPharma | 1.0 | $48M | 1.0M | 46.33 | |
| Viewray (VRAYQ) | 1.0 | $48M | 5.5M | 8.81 | |
| Adma Biologics (ADMA) | 0.9 | $45M | 12M | 3.87 | |
| Allogene Therapeutics (ALLO) | 0.9 | $42M | 1.5M | 26.85 | |
| Verrica Pharmaceuticals | 0.8 | $40M | 3.4M | 11.62 | |
| Kodiak Sciences (KOD) | 0.8 | $37M | 3.1M | 11.70 | |
| Momenta Pharmaceuticals | 0.8 | $36M | 2.9M | 12.45 | |
| Spark Therapeutics | 0.8 | $36M | 350k | 102.38 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $35M | 3.2M | 11.22 | |
| eHealth (EHTH) | 0.7 | $33M | 386k | 86.10 | |
| Vapotherm | 0.7 | $32M | 1.4M | 23.00 | |
| Invitae (NVTAQ) | 0.7 | $32M | 1.3M | 23.50 | |
| Neptune Wellness Solutions I | 0.6 | $30M | 8.9M | 3.37 | |
| Dbv Technologies S A | 0.6 | $30M | 3.6M | 8.22 | |
| Rocket Pharmaceuticals (RCKT) | 0.6 | $30M | 2.0M | 15.00 | |
| Cymabay Therapeutics | 0.6 | $28M | 3.9M | 7.16 | |
| Establishment Labs Holdings Ord (ESTA) | 0.6 | $28M | 1.3M | 21.99 | |
| Kadmon Hldgs | 0.6 | $27M | 13M | 2.06 | |
| Concert Pharmaceuticals I equity | 0.6 | $27M | 2.2M | 12.00 | |
| Vbi Vaccines | 0.5 | $25M | 26M | 0.95 | |
| Protagonist Therapeutics | 0.5 | $25M | 2.1M | 12.11 | |
| Uniqure Nv (QURE) | 0.5 | $22M | 282k | 78.15 | |
| Eidos Therapeutics | 0.5 | $21M | 687k | 31.08 | |
| Teladoc (TDOC) | 0.4 | $20M | 307k | 66.41 | |
| Stoke Therapeutics (STOK) | 0.4 | $20M | 672k | 29.17 | |
| Aldeyra Therapeutics (ALDX) | 0.4 | $19M | 3.1M | 6.00 | |
| Turning Point Therapeutics I | 0.4 | $17M | 425k | 40.70 | |
| Molecular Templates | 0.3 | $17M | 2.0M | 8.35 | |
| Marker Therapeutics Ord | 0.3 | $16M | 2.0M | 7.92 | |
| Bausch Health Companies (BHC) | 0.3 | $15M | 600k | 25.22 | |
| Urovant Sciences | 0.3 | $15M | 1.9M | 7.91 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $14M | 285k | 48.30 | |
| Motus Gi Hldgs Incorporated | 0.3 | $13M | 4.2M | 3.03 | |
| Morphic Hldg (MORF) | 0.3 | $13M | 650k | 19.82 | |
| Axonics Modulation Technolog (AXNX) | 0.2 | $12M | 286k | 40.97 | |
| Ideaya Biosciences (IDYA) | 0.2 | $11M | 1.1M | 9.96 | |
| Mei Pharma | 0.2 | $11M | 4.4M | 2.50 | |
| Foamix Pharmaceuticals | 0.2 | $11M | 4.7M | 2.38 | |
| Agile Therapeutics | 0.2 | $10M | 8.4M | 1.24 | |
| Fiat Chrysler Automobiles N | 0.2 | $10M | 62k | 161.42 | |
| Dex (DXCM) | 0.2 | $9.0M | 60k | 149.83 | |
| Ani Pharmaceuticals Inc. note 3.000 12/0 | 0.2 | $9.0M | 7.5M | 1.20 | |
| Aquestive Therapeutics | 0.2 | $8.9M | 2.1M | 4.20 | |
| Alector (ALEC) | 0.2 | $9.3M | 512k | 18.22 | |
| Acorda Therapeutics | 0.2 | $8.6M | 1.1M | 7.67 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $8.8M | 331k | 26.50 | |
| Shockwave Med | 0.2 | $8.6M | 150k | 57.09 | |
| Seres Therapeutics | 0.2 | $8.1M | 2.5M | 3.22 | |
| Intercept Pharmaceuticals In | 0.2 | $7.8M | 98k | 79.57 | |
| Synlogic | 0.2 | $7.9M | 868k | 9.10 | |
| Orchard Therapeutics Plc ads | 0.1 | $7.3M | 522k | 13.99 | |
| Vocera Communications | 0.1 | $6.2M | 194k | 31.92 | |
| Tenet Healthcare Corporation (THC) | 0.1 | $6.2M | 301k | 20.66 | |
| Rhythm Pharmaceuticals (RYTM) | 0.1 | $5.8M | 263k | 22.00 | |
| Translate Bio | 0.1 | $5.5M | 435k | 12.63 | |
| Rockwell Medical Technologies | 0.1 | $4.5M | 1.5M | 3.01 | |
| Health Sciences Acqustn Corp unit 04/01/2024 | 0.1 | $4.2M | 400k | 10.60 | |
| Twist Bioscience Corp (TWST) | 0.1 | $3.2M | 111k | 29.01 | |
| Female Health (VERU) | 0.1 | $3.1M | 1.4M | 2.13 | |
| Acasti Pharma | 0.0 | $2.0M | 1.8M | 1.14 | |
| CryoLife (AORT) | 0.0 | $1.5M | 50k | 29.94 | |
| Axsome Therapeutics (AXSM) | 0.0 | $1.4M | 54k | 25.74 | |
| Eiger Biopharmaceuticals | 0.0 | $1.5M | 140k | 10.59 | |
| Sierra Oncology | 0.0 | $1.5M | 2.7M | 0.56 | |
| Ferrari Nv Ord (RACE) | 0.0 | $1.0M | 6.2k | 161.45 | |
| Voyager Therapeutics (VYGR) | 0.0 | $996k | 37k | 27.23 | |
| Medicines Company | 0.0 | $712k | 20k | 36.45 | |
| ZIOPHARM Oncology | 0.0 | $528k | 91k | 5.83 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $567k | 46k | 12.32 | |
| Abeona Therapeutics Inc *w exp 12/19/201 | 0.0 | $620k | 660k | 0.94 | |
| Natera (NTRA) | 0.0 | $401k | 15k | 27.56 | |
| Tandem Diabetes Care (TNDM) | 0.0 | $414k | 6.4k | 64.47 | |
| Allena Pharmaceuticals | 0.0 | $539k | 132k | 4.07 | |
| Guardant Health (GH) | 0.0 | $571k | 6.6k | 86.29 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.0 | $452k | 179k | 2.52 | |
| Conformis | 0.0 | $436k | 100k | 4.36 | |
| Biogen Idec (BIIB) | 0.0 | $64k | 200k | 0.32 | |
| SPDR S&P Biotech (XBI) | 0.0 | $70k | 200k | 0.35 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $46k | 421k | 0.11 |